Cooper Human Systems   Report issue

For profit Phase 1 Phase 2 Phase 4
Founded: Nashua NH United States (2011)

Organization Overview

First Clinical Trial
2011
NCT03914118
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Cooper Green Mercy Health Systems | Cooper health system | The Cooper Health System

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acquired Immunodeficiency Syndrome (Phase 2)

Carotid Stenosis (Phase 4)

Clostridium Infections (Phase 4)

Cognitive Dysfunction (Phase 2)

Communicable Diseases (Phase 2)

Glioblastoma (Phase 1)

HIV Infections (Phase 2)

Infections (Phase 4)

Recurrence (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 9
  • # of Trial APIs: 20